PATENT CLAIM ANALYSIS

Application Number: 16007340
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "330000"]

Abstract:
The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.

Claim (Index 23):
A method of inhibiting the interaction of a C5a receptor with a C5a receptor ligand to treat Hidradenitis suppurativa (HS) or a HS-related disease in a subject, the method comprising administering to the subject an agent that specifically binds to C5, to the C5a receptor, or to the C5a receptor ligand, thereby inhibiting the interaction of the C5a receptor with the C5a receptor ligand and treating the disease.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 94.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14729865', '15127676', '13512334', '12011058', '10222464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7409713614022777
- 35 USC 102 Novelty (BERT): 0.5175327835735057
- Combined Prediction Score: 0.7186275036194005
- Mean Citation Score: 297.5676400000001
- Max Citation Score: 302.56268
- Similarity Product: 238.66178497893569

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test